Skip to main content

Regeneron Pharmaceuticals ownership: holders and insider trading

  • REGN · Nasdaq
  • Pharmaceuticals
  • Biotechnology
  • S&P 500
$955.47+0.45%Close 13 Nov 2026 · Market value $102.5B

Over the last twelve months, insiders sold $57.93M of shares on the open market, $14.61M of it under 10b5-1 plans set in advance, and bought none.

From the company's proxy statement, each holder's latest Schedule 13D or 13G, the institutional managers' quarterly 13F reports and the insiders' Form 4 filings. A percentage is shown as filed; one marked * is worked out here from the shares outstanding.

Largest holders

HolderTypeSharesOf the companySourceAs of
The Vanguard Group, Inc.Holder10.9M10.17%*Form 13F30 Jun 2026
BlackRock, Inc.Holder9.1M8.54%*Form 13F30 Jun 2026
Vanguard Capital ManagementHolder7.7M7.37%Schedule 13G31 Mar 2026
Dodge & CoxInstitution4.9M4.56%*Form 13F30 Jun 2026
State StreetInstitution4.8M4.53%*Form 13F30 Jun 2026
InvescoInstitution3.9M3.69%*Form 13F30 Jun 2026
JPMorgan ChaseInstitution3.8M3.54%*Form 13F30 Jun 2026
Leonard S. Schleifer, M.D., Ph.D.Insider2.9M2.8%Proxy statement24 Apr 2026
Franklin TempletonInstitution2.8M2.60%*Form 13F30 Jun 2026
Geode Capital ManagementInstitution2.6M2.46%*Form 13F30 Jun 2026
Nuveen (TIAA)Institution2.0M1.89%*Form 13F30 Jun 2026
Loomis Sayles & Co L PInstitution1.9M1.74%*Form 13F30 Jun 2026
Leonard S. Schleifer, M.D., Ph.D.Insider1.7M95% Class AProxy statement24 Apr 2026
George D. Yancopoulos, M.D., Ph.D.Insider1.7M1.6%Proxy statement24 Apr 2026
T. Rowe PriceInstitution1.5M1.43%*Form 13F30 Jun 2026
Morgan StanleyInstitution1.4M1.31%*Form 13F30 Jun 2026
Bank of AmericaInstitution1.3M1.21%*Form 13F30 Jun 2026
Wellington ManagementInstitution1.3M1.19%*Form 13F30 Jun 2026
Norges BankInstitution1.2M1.10%*Form 13F30 Jun 2026
Goldman SachsInstitution1.2M1.09%*Form 13F30 Jun 2026

Regeneron Pharmaceuticals has several share classes; each percentage is of the class the filer names.

Insider transactions latest 25

InsiderDateTransactionSharesPriceValue
Pitofsky Jason · SVP Controller4 Nov 2026Option exercise+1.5K$726.53$1.09M
Pitofsky Jason · SVP Controller4 Nov 2026Option exercise+1.5K$644.54$952.6K
Pitofsky Jason · SVP Controller4 Nov 2026Option exercise+905$492.00$445.3K
Pitofsky Jason · SVP Controller4 Nov 2026Open-market sale−439$939.57$412.5K
Pitofsky Jason · SVP Controller4 Nov 2026Open-market sale−575$940.46$540.8K
Pitofsky Jason · SVP Controller4 Nov 2026Open-market sale−982$941.58$924.6K
Pitofsky Jason · SVP Controller4 Nov 2026Open-market sale−1.2K$942.31$1.14M
Pitofsky Jason · SVP Controller4 Nov 2026Open-market sale−529$943.53$499.1K
Pitofsky Jason · SVP Controller4 Nov 2026Open-market sale−108$944.22$102.0K
Pitofsky Jason · SVP Controller4 Nov 2026Open-market sale−35$945.61$33.10K
Pitofsky Jason · SVP Controller4 Nov 2026Open-market sale−179$950.76$170.2K
Zoghbi Huda Y · Director3 Nov 2026Option exercise+7.4K$380.95$2.83M
Zoghbi Huda Y · Director3 Nov 2026Open-market sale−6.9K$970.42$6.73M
Zoghbi Huda Y · Director3 Nov 2026Open-market sale−500$971.06$485.5K
Fenimore Christopher R. · EVP Finance CFO2 Nov 2026Option exercise+6.0K$381.92$2.29M
Fenimore Christopher R. · EVP Finance CFO2 Nov 2026Shares withheld for tax−4.2K$950.50$4.03M
LAROSA JOSEPH J · EVP General Counsel and Secret2 Nov 2026Option exercise+12.3K$381.92$4.69M
LAROSA JOSEPH J · EVP General Counsel and Secret2 Nov 2026Shares withheld for tax−8.7K$950.50$8.26M
LAROSA JOSEPH J · EVP General Counsel and Secret2 Nov 2026Open-market sale−3.9K$965.41$3.80M
LAROSA JOSEPH J · EVP General Counsel and Secret2 Nov 2026Open-market sale−527$966.11$509.1K
SING GEORGE L · Director2 Nov 2026Option exercise+7.8K$376.69$2.95M
SING GEORGE L · Director2 Nov 2026Option exercise+7.4K$380.95$2.83M
SING GEORGE L · Director2 Nov 2026Open-market sale−1.2K$960.57$1.18M
SING GEORGE L · Director2 Nov 2026Open-market sale−540$961.85$519.4K
SING GEORGE L · Director2 Nov 2026Open-market sale−2.5K$962.61$2.43M

Form 4 filings since 16 Nov 2024: purchases and sales, grants, option exercises and shares withheld for tax. Gifts and other transfers are left out.

REGN in the terminal

Holders over eight quarters by family, every Form 4 and Form 144 back two years, and alerts on insider buying.